Remifentanil ( DrugBank: Remifentanil )

2 diseases

ID	Disease name (Link within this page)	Number of trials
6	Parkinson disease	2
70	Spinal stenosis	2

6. Parkinson disease

Clinical trials : 2,307 / Drugs : 2,007 - (DrugBank : 349) / Drug target genes : 188 - Drug target pathways : 199

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR1900021760	2019-03-09	2019-03-08	Effect-site concentration of remifentanil for I-gel insertion in male patients with Parkinson’s disease undergoing deep brain stimulator implantation during target-controlled infusion of propofol	Effect-site concentration of remifentanil for I-gel insertion in male patients with Parkinson’s disease undergoing deep brain stimulator implantation during target-controlled infusion of propofol	Parkinson’s disease	Parkinson’s disease:propofol and remifentanil;Non-Parkinson’s disease:propofol and remifentanil;	The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China	NULL	Recruiting	40	64	Male	Parkinson’s disease:25;Non-Parkinson’s disease:25;	N/A	China
2	NCT00615472 (ClinicalTrials.gov)	October 2003	9/1/2008	Intravenous Versus Inhalational Anesthesia in Parkinson's Disease	Intravenous General Anesthesia Versus Inhalational General Anesthesia in Parkinson's Disease	Parkinson's Disease	Drug: Isoflurane;Drug: Remifentanil;Drug: Propofol	Columbia University	NULL	Terminated	18 Years	N/A	All	58	N/A	United States

Clinical trials : 95 / Drugs : 169 - (DrugBank : 61) / Drug target genes : 68 - Drug target pathways : 90

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR-TRC-13003639	2012-09-13	2013-09-07	The application of Analgesia Nociception Index guided Remifentanil administration during general anesthesia for Spinal Surgery	The application of Analgesia Nociception Index guided Remifentanil administration during general anesthesia for Spinal Surgery	Lumbar spinal stenosis and/or lumbar intervertebral disc herniation	ANI group:ANI guide the administration of remifentanil;control group:remifentanil was adapted by Anaesthesiologist corresponding to clinical experiences ;	Peking University Third Hospital	NULL	Completed	18	70	Both	ANI group:30;control group:30;		China
2	NCT01052324 (ClinicalTrials.gov)	March 2010	11/1/2010	The Effect Site Concentration of Remifentanil for Conscious Sedation During Awake Nasotracheal Fiberoptic Intubation	The Effect Site Concentration of Remifentanil for Conscious Sedation During Awake Nasotracheal Fiberoptic Intubation	Cervical Disc Herniation;Cervical Spinal Stenosis;Cervical Spine Damage	Drug: Remifentanil	Yonsei University	NULL	Completed	20 Years	65 Years	Both	19	Phase 4	Korea, Republic of